Pharmacists’ Role in Blood Pressure Control
A special issue of Pharmacy (ISSN 2226-4787).
Deadline for manuscript submissions: closed (31 August 2020) | Viewed by 337
Special Issue Editor
Special Issue Information
Dear Colleagues,
Hypertension is a major cause of morbidity and mortality, and hypertension causes an estimated 395,000 deaths in the US each year: one out of every six deaths. Hypertension is second only to smoking as a modifiable cause of death in the US. Poor blood pressure control increases the risk of myocardial infarction, stroke, and death and is often due to delays in diagnosis and treatment intensification. These delays often occur because patients only visit their physicians annually or semi-annually. Pharmacists are medication experts and often more available to patients. Indeed, clinic-based pharmacist interventions to control blood pressure have been shown to be both effective and cost-effective. However, more research in this area is needed, especially in the community setting. Pharmacist interventions that are sustainable are also needed.
We invite you to submit articles for this Special Issue on pharmacist interventions for blood pressure control. We welcome research studies of pharmacist interventions in clinical and community settings. Reports of new interventions as well as analysis of data from previous interventions will be accepted. Studies of barriers, challenges, and best practices are also welcome.
Prof. Dr. Linnea A. Polgreen
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Pharmacist
- Blood pressure control
- Treatment
- Intervention
- Hypertension
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
